Skip to main content
EssilorLuxottica logo

EssilorLuxottica — Investor Relations & Filings

Ticker · EL ISIN · FR0014007HJ5 LEI · 549300M3VH1A3ER1TB49 PA Manufacturing
Open in API
Filings indexed 1,139 across all filing types
Latest filing 2024-02-12 Share Issue/Capital Cha…
Country FR France
Listing PA EL

About EssilorLuxottica

https://www.essilorluxottica.com/

EssilorLuxottica is a global leader in the design, manufacture, and distribution of ophthalmic lenses, prescription frames, and sunglasses. The company operates a vertically integrated business model, managing a comprehensive portfolio of proprietary and licensed eyewear and vision care brands. Its activities encompass the production of advanced vision care products, including lenses and optical instruments, as well as a wide range of eyewear. EssilorLuxottica distributes its products through a global network of wholesale and retail channels, serving consumers with solutions for their vision needs and personal style.

Recent filings

Filing Released Lang Actions
EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of January 31, 2024
Share Issue/Capital Change Classification · 95% confidence The document explicitly states it is a 'Disclosure of Share Capital and Voting Rights Outstanding as of January 31, 2024', referencing French Commercial Code and AMF regulations. It provides the exact number of shares outstanding and voting rights. This type of mandatory disclosure regarding the total number of shares and voting power, often required periodically by regulators, aligns best with filings related to significant share structure changes or ownership notifications. While it is not a Director's Dealing (DIRS) or a Major Shareholding Notification (MRQ) about a specific shareholder crossing a threshold, it is a formal announcement detailing the total voting capital structure. Among the provided codes, 'Declaration of Voting Results & Voting Rights Announcements' (DVA) is the closest fit for a formal announcement detailing the total voting rights outstanding, even if it's not the result of a specific vote, as it concerns the fundamental voting structure. However, given the context of mandatory disclosure of share capital, it is also very close to a general regulatory filing. Since it is a specific disclosure about the total voting rights outstanding, DVA is the most precise fit over the general RNS.
2024-02-12 English
EssilorLuxottica: Full-Year 2023 Results Conference Call Invitation
Call Transcript Classification · 98% confidence The document is explicitly titled "Full-Year 2023 Results Conference Call Invitation." It provides details (date, time, dial-in links, webcast link) for an upcoming conference call where the company's full-year results will be discussed. This content is an invitation to a conference call, not the transcript of the call itself, nor is it the full Annual Report (10-K). The closest matching category is 'Call Transcript' (CT), but since this is an *invitation* to the call, and not the transcript itself, it functions as an announcement related to the results discussion. However, given the provided definitions, the content is most directly related to the event where the results will be discussed. Since 'CT' is defined as the 'Full text transcript of company conference calls (like earnings calls with Q&A)', and this is an invitation to that call, it is a precursor announcement. If the document were the transcript, CT would be correct. If it were the press release of the results, ER would be correct. Since it is an invitation to the call where results are discussed, and there is no specific 'Call Invitation' code, I must evaluate the closest fit. An invitation to an earnings call is highly related to the 'Earnings Release' (ER) event, but the document itself is an invitation. Given the options, and recognizing that the core event is the results discussion, if the document were the transcript, it would be CT. Since it is an invitation to the call, it is a specific type of announcement. If we strictly follow the definitions, this is an announcement about an upcoming event where results will be discussed. It is not the transcript (CT), nor the earnings release (ER). It is an announcement about the call itself. In many filing systems, such an invitation might fall under RNS or a specific 'IR' (Investor Relations) communication. Given the strong focus on the conference call event, 'CT' is the most contextually relevant category, even though it's an invitation rather than the transcript itself, as it pertains directly to the call proceedings. However, applying the 'MENU VS MEAL' rule, this is an announcement about an event, not the content of the event. Since there is no specific 'Call Announcement' code, and it is not the transcript (CT), the most appropriate general category for an investor-facing announcement that doesn't fit elsewhere is 'RNS' (Regulatory Filings/Miscellaneous). Re-evaluating: The document is an invitation to the 'Results Conference Call'. This is a key investor relations activity. If the document were the transcript, it would be CT. If it were the press release, it would be ER. As an invitation, it is a specific type of investor communication. Given the high specificity of the codes, and the fact that it is an invitation to discuss results, it is a strong candidate for a general investor communication code. I will classify it as 'RNS' as a miscellaneous investor announcement, as it is not the transcript (CT) or the earnings release (ER).
2024-02-01 English
EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of December 31, 2023
Share Issue/Capital Change Classification · 95% confidence The document is titled "Disclosure of Share Capital and Voting Rights Outstanding as of December 31, 2023" and explicitly references French regulatory articles (Commercial Code and AMF General Regulations). It provides a precise breakdown of the number of shares outstanding and the corresponding voting rights as of a specific date (December 31, 2023). This type of mandatory disclosure regarding the total number of shares and voting power is a specific regulatory filing related to capital structure and ownership transparency, but it is not a general capital change (SHA) or a director's dealing (DIRS). It is a specific disclosure of the total voting rights outstanding. Among the provided codes, this most closely aligns with a mandatory regulatory disclosure concerning share capital/voting rights, which often falls under general regulatory announcements (RNS) or, if it were a specific US SEC form, might be related to ownership reporting. Given the context of mandatory disclosure of total voting rights, and lacking a specific code for 'Total Voting Rights Disclosure', it fits best as a general Regulatory Filing (RNS) or potentially a Share Issue/Capital Change (SHA) if interpreted broadly. However, since it is a periodic disclosure of the *total* outstanding rights rather than a transaction (like a buyback or new issue), RNS is the most appropriate general regulatory category for this specific, non-standard report type, as it is a mandatory disclosure required by the AMF.
2024-01-23 English
EssilorLuxottica: Nombre total de droits de vote et d’actions composant le capital social au 31 décembre 2023
Share Issue/Capital Change Classification · 95% confidence The document is titled "Nombre total de droits de vote et d'actions composant le capital social au 31 décembre 2023" (Total number of voting rights and shares comprising the share capital as of December 31, 2023). It explicitly references French regulatory articles (Code de Commerce and AMF regulations) and provides a precise count of shares and voting rights as of a specific date (December 31, 2023). This type of mandatory disclosure regarding the total number of shares and voting rights is typically classified as a regulatory filing or a specific notification related to capital structure/shareholding, often required periodically. Given the options, it is a specific notification about the capital structure and voting rights, which is a form of regulatory disclosure. It is not a full Annual Report (10-K), an Earnings Release (ER), or a Dividend Notice (DIV). It most closely aligns with a specific regulatory disclosure that doesn't fit the other precise categories. Since it details the capital structure and voting rights, it is a specific regulatory announcement. While it relates to share capital, it is not a transaction (POS) or a general share issue (SHA). It is a mandatory disclosure of the current state of voting rights. This fits best under the general 'Regulatory Filings' (RNS) as a specific, non-standard disclosure, or potentially related to 'Major Shareholding Notification' (MRQ) if it were about a change, but here it's a static count. Given the context of mandatory disclosure under AMF rules regarding the total number of shares/votes, RNS is the most appropriate fallback for specific regulatory updates that aren't covered by the other codes.
2024-01-23 French
EssilorLuxottica: Pour sa première participation au CES 2024 à Las Vegas, EssilorLuxottica présente ses dernières innovations en matière de smart glasses et de lunettes avec aide auditive intégrée
Regulatory Filings Classification · 100% confidence The document is a press release dated January 9, 2024, announcing EssilorLuxottica's participation in CES 2024 and showcasing new technology products like Nuance Audio (smart glasses with integrated hearing aids) and Ray-Ban Meta. It details product launches, strategic direction, and includes contact information for Investor Relations and Corporate Communications. This type of announcement, focusing on product innovation, strategic updates, and general corporate news outside of mandatory financial filings (like 10-K, ER, or IR), most closely aligns with a general corporate announcement or press release. Since there is no specific category for a general press release about product innovation, and it is not a formal financial report, management discussion, or earnings release, it falls best under the 'Regulatory Filings' (RNS) category as a general corporate disclosure, or potentially 'Investor Presentation' (IP) if it were structured as a presentation deck, but given the format, RNS is the most appropriate fallback for a non-standard, non-financial regulatory announcement.
2024-01-09 French
EssilorLuxottica showcases its smart and hearing aided eyewear innovation with first appearance at CES 2024 in Las Vegas
Environmental & Social Information Classification · 99% confidence The document is a press release dated January 9, 2024, announcing EssilorLuxottica's participation and product showcases (Nuance Audio, Ray-Ban Meta) at CES 2024. It discusses product innovation, market strategy, and includes contact information for Investor Relations and Corporate Communications. This type of announcement, focusing on business updates, product launches, and general corporate news that doesn't fit specific financial reporting categories (like 10-K, ER, or DIV), is best classified as a general Regulatory Filing or announcement. Since it is not a formal financial report, a transcript, or a management discussion, the most appropriate general category is Regulatory Filings (RNS), which serves as a broad category for non-standard corporate announcements.
2024-01-09 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.